Our previous study showed that rFGF21 administration increases PPARγ DNA-binding activity three days after stroke in the perilesion cortex of T2DM mice, which might be partially responsible for the reduction of brain tissue damage and detrimental proinflammatory cytokine expressions [10]. The gene discussed is PPARG; the disease is Stroke.